4-Bromo-2-chloro-3-(trifluoromethyl)pyridine
|
- $613 - $2376
- Product name: 4-Bromo-2-chloro-3-(trifluoromethyl)pyridine
- CAS: 1211589-92-2
- MF: C6H2BrClF3N
- MW: 260.44
- EINECS:
- MDL Number:MFCD16609905
- Synonyms:4-Bromo-2-chloro-3-(trifluoromethyl)pyridine;Pyridine, 4-bromo-2-chloro-3-(trifluoromethyl)-
5 prices
Selected condition：
Brand
- Alichem
- Chemenu
- Crysdot
Package
- 250mg
- 500mg
- 1g
- 5g
- ManufacturerAlichem
- Product number1211589922
- Product description4-Bromo-2-chloro-3-(trifluoromethyl)pyridine
- Packaging250mg
- Price$734.4
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number1211589922
- Product description4-Bromo-2-chloro-3-(trifluoromethyl)pyridine
- Packaging500mg
- Price$1019.2
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM318144
- Product description4-Bromo-2-chloro-3-trifluoromethylpyridine 95%
- Packaging1g
- Price$613
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11330346
- Product description4-Bromo-2-chloro-3-trifluoromethylpyridine 95+%
- Packaging1g
- Price$650
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11330346
- Product description4-Bromo-2-chloro-3-trifluoromethylpyridine 95+%
- Packaging5g
- Price$2376
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Alichem | 1211589922 | 4-Bromo-2-chloro-3-(trifluoromethyl)pyridine | 250mg | $734.4 | 2021-12-16 | Buy |
| Alichem | 1211589922 | 4-Bromo-2-chloro-3-(trifluoromethyl)pyridine | 500mg | $1019.2 | 2021-12-16 | Buy |
| Chemenu | CM318144 | 4-Bromo-2-chloro-3-trifluoromethylpyridine 95% | 1g | $613 | 2021-12-16 | Buy |
| Crysdot | CD11330346 | 4-Bromo-2-chloro-3-trifluoromethylpyridine 95+% | 1g | $650 | 2021-12-16 | Buy |
| Crysdot | CD11330346 | 4-Bromo-2-chloro-3-trifluoromethylpyridine 95+% | 5g | $2376 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|